HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chronic bifemelane hydrochloride administration enhances muscarinic cholinergic receptor binding in the senescent rat brain.

Abstract
In senescent rats, the binding ability of muscarinic cholinergic receptors (MCR) was markedly decreased in the cerebral cortex, hippocampus, thalamus, and the striatum compared with young adult rats. This decrease was markedly improved by chronic administration of bifemelane hydrochloride (bifemelane). In view of the findings that bifemelane markedly inhibits the decrease in acetylcholine (ACh) associated with cerebral ischemia, and that it improves amnesia induced by scopalamine, it may be inferred that bifemelane acts on the pre- and post-synaptic ACh neuronal systems. It may improve memory disturbance due to aging or cerebral ischemia, decreased conscious level, and decreased motor function.
AuthorsN Ogawa, K Mizukawa, K Haba, M Asanuma, A Mori
JournalJournal of medicine (J Med) Vol. 22 Issue 1 Pg. 17-27 ( 1991) ISSN: 0025-7850 [Print] United States
PMID2072048 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Benzhydryl Compounds
  • Receptors, Muscarinic
  • bifemelane
Topics
  • Aging (metabolism)
  • Animals
  • Autoradiography
  • Benzhydryl Compounds (pharmacology)
  • Brain (metabolism)
  • Male
  • Rats
  • Rats, Inbred Strains
  • Receptors, Muscarinic (metabolism)
  • Time Factors
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: